HCA Healthcare, Inc.·4

Feb 5, 6:22 PM ET

Cuffe Michael S. 4

4 · HCA Healthcare, Inc. · Filed Feb 5, 2026

Research Summary

AI-generated summary of this filing

Updated

HCA Healthcare EVP Michael S. Cuffe Sells 1,500 Shares

What Happened
Michael S. Cuffe, Executive Vice President and Chief Clinical Officer of HCA Healthcare (HCA), reported two transactions on Feb 3, 2026: an open-market (or private) sale of 1,500 shares at $498.09 each for total proceeds of $747,135, and a gift of 4,050 shares (reported at $0.00). The Form 4 covering these transactions was filed on Feb 5, 2026.

Key Details

  • Transaction date: 2026-02-03; Form 4 filed: 2026-02-05.
  • Sale (code S): 1,500 shares @ $498.09 = $747,135 (open market/private sale).
  • Gift (code G): 4,050 shares @ $0.00 = $0 (reported as a gift).
  • Shares owned after the transactions: not specified in the information provided here.
  • No 10b5-1 or tax-withholding footnotes were noted in the supplied summary; filing shows no late-filing indicator.

Context
Sales reduce an insider’s holdings and can be routine (liquidity, diversification, planned sales); gifts are transfers for non-market reasons (estate planning, charitable giving) and do not necessarily signal the insider’s view of the company. There were no option exercises or derivative transactions reported in this filing.

Insider Transaction Report

Form 4
Period: 2026-02-03
Cuffe Michael S.
EVP and Chief Clinical Officer
Transactions
  • Sale

    Common Stock

    2026-02-03$498.09/sh1,500$747,13530,002.902 total
  • Gift

    Common Stock

    2026-02-034,05025,952.902 total
Signature
/s/ Kevin A. Ball, Attorney-in-Fact|2026-02-05

Documents

1 file
  • 4
    ownership.xmlPrimary

    4